BIOMAT Database Logo BIOMAT Database Logo

Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody. 2010

Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Medical Isotopes Research Center, Peking University, Beijing 100191, China.

Radioimmunotherapy (RIT) is a promising approach for the treatment of a wide variety of malignancies. The aim of this study was to investigate the therapeutic efficacy of (131)I-labeled anticarcinoembryonic antigen (CEA) monoclonal antibody CL58 in a human colon cancer mouse model. In vitro and in vivo characteristics of (125)I-CL58 were evaluated in LS180 human colon cancer cells and the nude mouse model. (131)I-CL58 was prepared and its in vivo therapeutic efficacy was tested. (125)I-CL58 showed high affinity to LS180 cells, as well as high tumor uptake and long tumor retention in LS180 tumor xenografts. (131)I-CL58 exhibited dose-dependent inhibition of LS180 tumor growth. With the excellent in vitro and in vivo characteristics, and the effective therapy for colon cancer in animal model, (131)I-CL58 is a promising agent for RIT of CEA-positive tumors including colon cancer.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
December 1995, Cancer research,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2.
November 2006, International journal of radiation oncology, biology, physics,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4.
May 1997, International journal of cancer,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibody.
March 2014, Cancer biotherapy & radiopharmaceuticals,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Treatment of intracranial human glioma xenografts with 131I-labeled anti-tenascin monoclonal antibody 81C6.
May 1988, Cancer research,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
March 1990, Cancer research,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3.
September 1995, Cancer immunology, immunotherapy : CII,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Radioimmunotherapy of peritoneal human colon cancer xenografts with site-specifically modified 212Bi-labeled antibody.
February 1990, Cancer research,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.
March 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Zhaofei Liu, and Cunjing Jin, and Zilin Yu, and Jing Zhang, and Yan Liu, and Huiyun Zhao, and Bing Jia, and Fan Wang
Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.
March 1993, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!